SCHEMBL7091098

SCHEMBL7091098

CC(=O)OC1OCCc2cc(Br)ccc21

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAMK2A Q9UQM7 1/20 0.39
RAB9A P51151 2/20 0.37
SRD5A1 P18405 2/20 0.36
HSD17B3 P37058 3/20 0.34
HTT P42858 2/20 0.33
MAPT P10636 1/20 0.33
SRD5A2 P31213 1/20 0.33
MAPK1 P28482 2/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
BRCA1 P38398 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
HPGD P15428 1/20 0.32
THRB P10828 1/20 0.32
YWHAG P61981 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20700070 0.85 NCEH1 (0.39) CAMK2ARAB9ASRD5A1HTTMAPT
SCHEMBL15912427 0.78 RAB9A (0.48) CAMK2ARAB9ASRD5A1HSD17B3HTT
SCHEMBL27787753 0.75 SRD5A1 (0.44) CAMK2ASRD5A1HSD17B3MAPK1MEN1
SCHEMBL31730735 0.75 RAB9A (0.48) CAMK2ARAB9ASRD5A1HTTMAPT
SCHEMBL20700449 0.75 NCEH1 (0.39) RAB9ARECQL
SCHEMBL23286931 0.74 RAB9A (0.49) CAMK2ARAB9ASRD5A1HTTMAPT
SCHEMBL27571543 0.73 SRD5A1 (0.33) CAMK2ASRD5A1HTTMAPTLMNA
SCHEMBL31394626 0.72 SRD5A1 (0.39) CAMK2ARAB9ASRD5A1YWHAG
SCHEMBL27285662 0.72 CAMK2A (0.42) CAMK2ARAB9ASRD5A1HTTMAPT
SCHEMBL15919083 0.72 RAB9A (0.43) CAMK2ARAB9AHTTMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345930-A2 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2003-09-24 EP disclosed
WO-2002050067-A2 PHARMACEUTICAL HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 2002-06-27 WO disclosed